TREM1 and irritable bowel syndrome: For example, serum TREM-1 down-regulation joined with a high amount of mucosal plasma cells and macrophages in colonic samples may predict non-responsiveness to anti-TNF therapy in IBD patients [40], though this approach needs to be further validated [41,42].